Peptides of natural and synthetic sources are compounds operating in a wide range of
biological interactions. They play a key role in biotechnological applications as both …

Liposomes represent a widely varied and malleable class of drug carriers generally
characterized by the presence of one or more amphiphile bilayers enclosing an interior …

Synthetic methodologies integrating hydrophobic drug delivery and biomolecular targeting
with mesoporous silica nanoparticles are described. Transferrin and cyclic‐RGD peptides …

Real-time monitoring of tumor drug delivery in vivo is a daunting challenge due to the
heterogeneity and complexity of the tumor microenvironment. In this study, we developed a …

For anti-tumor therapy different strategies have been employed, eg, radiotherapy,
chemotherapy, or immunotherapy. Notably, these approaches do not only address the tumor …

Since they were first reported in 1980, site-specific drug delivery nanocarriers have
progressed greatly with the development of nanotechnology and biotechnology, especially …

This review describes strategies for the delivery of therapeutic radionuclides to tumor sites.
Therapeutic approaches are summarized in terms of tumor location in the body, and tumor …

Liposomal formulations of anticancer agents have been developed to prolong drug
circulating lifetime, enhance anti-tumor efficacy by increasing tumor drug deposition, and …

Since their discovery by Bangham about 50 years ago, liposomes have become promising
tools in drug delivery systems. This has increased the therapeutic index of many drugs, and …

Chemotherapy has been widely used in breast cancer patients to reduce tumor size.
However, most anticancer agents cannot differentiate between cancerous and normal cells …